Table 1: Characteristics of our patients

Patients

Age at onset

Sex

Clinical features

Location

Photosensitivity

Histology

DIF

Serology

Systemic manifetations

Treatment

Follow up

1

14 years

M

DLE

Face Neck Thorax

Yes

CLE

ND

N

Absent

Sun protection H-chloroquine

5 months

2

15 years

F

DLE

Face Ears

Yes

CLE

Positive

ANA +

Absent

Sun protection H-chloroquine

1 month

3

11 years

F

DLE

Face

Yes

CLE

ND

N

Absent

Sun protection Topical steroids

2 months

4

14 years

F

SLE

Face Upper limbs

Yes

LE

ND

ANA + Antinative DNA + Anti-ENA

Arthritis

Sun protection H-chloroquine Systemic steroids

3 months

5

10 years

M

SLE

Face Lower and upper limbs

Yes

LE

Positive

ANA + Antinative DNA + Cp

Lupus nephritis Pericarditis Pleuresy Hemolytic anemia Arterial thrombosis

Sun protection H-chloroquine Systemic steroids

8 years

6

10 years

M

SLE

Face Scalp (alopecia) Thorax Arms

Yes

LE

Positive

ANA + Cp

Arthritis

Sun protection H-chloroquine Systemic steroids

2 months

M: male, F: female, DLE: discoid lupus erythematosus, SLE: systemic lupus erythematosus, CLE: chronic lupus erythematosus, ANA: antinuclear antibodies, DIF: direct immunofluorescence, CLE: chronic lupus erythematosus, ND: not done, LE lupus erythematosus, H-chloroquine: hydroxychloroquine.